Acoustic Resonance Therapy is the only nasal-congestion therapy whose efficacy has been demonstrated against a sham control in a multi-center, randomized, double-blinded trial — and the only one to start working in 15 minutes.
A rigorous multi-center, randomized, double-blinded, sham-controlled, interventional study evaluating Acoustic Resonance Therapy delivered via a vibrational headband.
Adults enrolled across multiple sites with moderate-to-severe nasal congestion
Active ART vs. non-therapeutic sham device — neither patient nor investigator unblinded during data collection
Two 15-minute sessions per day at home, with daily symptom diary
Mean change from baseline in the nasal congestion sub-score of the Total Nasal Symptom Score
Aggregated symptom score across congestion, rhinorrhea, itch, and sneezing
FDA-cleared for patients 12 years and older
Most over-the-counter and prescription nasal congestion therapies are studied as open-label comparisons or against active controls. SONU was tested against a non-therapeutic sham with full blinding — the highest bar for demonstrating that benefit comes from the therapy itself, not placebo response or expectation.
The result: a statistically significant improvement in nasal congestion and total nasal symptoms within the 2-week protocol — and meaningful symptom relief beginning within 15 minutes of the first session.
SONU has been clinically shown to relieve the four symptoms that define both allergic and non-allergic rhinitis in adults and adolescents 12+.
For adults and children 12 years and older, SONU can be used twice daily for 5–15 minutes per session. Additional sessions as needed are clinically safe.
"Patients want something they can do at home, drug-free, that actually works. The trial demonstrated meaningful TNSS improvement against a sham control — that's the bar we need in this space."
For patients who can’t tolerate, don’t respond to, or want to avoid chronic intranasal steroid use, SONU offers a clinically validated, drug-free alternative or adjunct.
A one-time AI-driven facial scan calibrates the SONU device to the patient's unique sinus and airway anatomy — no two protocols are identical.
Patients wear SONU for 15 minutes, twice daily. Acoustic resonance vibration mobilizes congested mucus and reduces inflammation in the sinonasal cavities.
Adherence and patient-reported outcomes flow to the clinician portal — so you can identify non-responders or escalate care between visits.
A one-time AI-driven facial scan calibrates the SONU device to the patient's unique sinus and airway anatomy — no two protocols are identical.
Patients wear SONU for 15 minutes, twice daily. Acoustic resonance vibration mobilizes congested mucus and reduces inflammation in the sinonasal cavities.
Adherence and patient-reported outcomes flow to the clinician portal — so you can identify non-responders or escalate care between visits.
The Spatial Sleep wellness headband uses the same Acoustic Resonance Therapy platform, customized for sleep. Clinical evaluation led by Stanford Sleep Medicine demonstrated significant, durable improvements in patient-reported sleep quality and insomnia severity.
Useful as an adjunct to CPAP, behavioural therapy for insomnia, and dental airway treatment — or as a first-line, drug-free option for patients reluctant to start sedative-hypnotics.
Our clinical team can share peer-reviewed manuscripts, conference posters, FDA documentation, and ongoing real-world evidence with credentialed clinicians, formulary committees, and researchers.
